The Food and Drug Administration approved a new Alzheimer’s treatment called donanemab on Tuesday, clearing the way for the third addition to a new class of drugs aimed at slowing the brain’s decline… [+6909 chars]Read More
FDA approves new Alzheimers treatment donanemab from Eli Lilly CBS News
